Psoriatic arthritis claims get underrated all the time because the psoriasis is obvious and the joint damage usually is not. The rash gets documented. The hands that won’t close, the feet that hurt every morning, and the fatigue draining your day often do not.
Quick Answer
The VA rates psoriatic arthritis under Diagnostic Code 5002 as either an active process (20% to 100%) or based on chronic residual joint damage, whichever is higher. Psoriatic arthritis can be rated separately from psoriasis, which is rated under DC 7816 for skin coverage and treatment type. Most claims stay low because both conditions get lumped under one code instead of being evaluated independently.
How Does the VA Rate Psoriatic Arthritis?
Psoriatic arthritis falls under DC 5002, but the way most files are built, the VA never gets to that code. The skin is already documented and rated under DC 7816 for psoriasis, and the joint damage gets folded into that evaluation instead of standing on its own. The rating follows the same structure as other systemic arthritis: active process or chronic residuals, whichever is higher.
But here is what makes psoriatic arthritis different from every other arthritis VA rating claim. It often exists alongside psoriasis, which is a skin condition rated under a completely separate diagnostic code. That means a veteran with both conditions can potentially receive two separate ratings, one for the skin under DC 7816 and one for the joints under DC 5002, as long as the file clearly shows that each rating covers different symptoms.
The VA cannot rate the same symptom twice. That is called pyramiding. But the skin symptoms and the joint symptoms are not the same thing, and when the record separates them clearly, both ratings can stand.
Can You Get Separate VA Ratings for Psoriasis and Psoriatic Arthritis?
Yes. This is the part most veterans miss, and it is usually the most valuable angle in the entire claim.
Psoriasis is rated under DC 7816 based on how much of the body is affected and whether you need systemic therapy. If you are on immunosuppressive medication like methotrexate or a biologic for more than six weeks a year, that alone can support a 30% or 60% skin rating. The joints are a separate issue. If psoriatic arthritis is causing incapacitating episodes, functional limitations, or systemic health effects, that gets rated under DC 5002 on its own.
Where this breaks down is when the VA rates everything under one code. We see files where the decision letter says something like “psoriasis with psoriatic arthritis, 60% under DC 7816.” That rolls the arthritis into the skin rating and leaves the joint component completely unaccounted for. If that happened to you, there is likely a missing rating sitting in your file.
If your VA decision letter shows psoriasis and psoriatic arthritis rated together under one diagnostic code, that is worth a closer look. The skin symptoms and joint symptoms are evaluated under different criteria, and separating them can change the combined rating significantly.
Why Do Most Psoriatic Arthritis VA Ratings Stay Low?
Most psoriatic arthritis claims stay low because the joints never get their own evaluation. The psoriasis is visible, it gets documented, and the VA rates it under the skin code. The arthritis is happening underneath, but unless it is specifically claimed and separated in the record, it gets absorbed into a rating that was never designed to measure joint damage.
When both conditions are rolled into the psoriasis skin rating, the joint damage, the flares, the loss of function, and the systemic effects all get absorbed into a code that was designed to evaluate skin coverage and medication use. The DC 5002 criteria, which look at incapacitating episodes and overall health impact, never get applied.
What Are the VA Rating Percentages for Psoriatic Arthritis?
Psoriatic arthritis is rated under DC 5002 as an active process. These are the joint ratings, separate from the psoriasis skin rating.
The practical ceiling for most PsA claims:
A veteran has psoriasis rated at 60% because they are on Humira. The same Humira is treating their psoriatic arthritis, which was never claimed separately. The joints still flare, the fingers swell, and grip strength comes and goes, but because the arthritis was never split out, none of that is reflected in the rating. The skin medication covers both conditions, but the rating only counts one.
How Is Psoriatic Arthritis Different From Rheumatoid Arthritis and Degenerative Arthritis?
All three are rated under different frameworks, and confusing them is one of the fastest ways to end up with a lower rating.
- Degenerative arthritis is wear-and-tear damage rated under DC 5003, based on range of motion loss.
- Rheumatoid arthritis is autoimmune and attacks joints symmetrically, rated under DC 5002.
- Psoriatic arthritis is also autoimmune and rated under DC 5002, but it behaves differently. It often hits asymmetrically, targets the small joints at the tips of the fingers and toes, and can cause dactylitis, where entire fingers or toes swell. It also involves the tendons and ligaments in ways that RA typically does not.
Those patterns matter because they are the clinical signs that distinguish PsA from generic joint pain in the record, and if the examiner is not looking for them, they don’t get documented.
The biggest practical difference for VA claims is that psoriatic arthritis almost always comes with a skin condition that qualifies for its own separate rating. That dual-rating structure does not exist with RA or degenerative arthritis, and it is the single most overlooked opportunity in these claims.
How Do You Prove Service Connection for Psoriatic Arthritis?
The most common path is secondary to psoriasis. If psoriasis is already service-connected and psoriatic arthritis develops later, the medical literature supports that connection directly. About 30% of people with psoriasis eventually develop psoriatic arthritis, and it often shows up a decade or more after the skin condition started. A provider opinion linking the two is usually enough to establish the secondary claim.
Direct service connection is also possible if the arthritis appeared during or shortly after service. Like rheumatoid arthritis, psoriatic arthritis is classified as a chronic disease, so if symptoms reached a compensable level within one year of discharge, the presumption of service connection can apply.
For veterans with toxic exposure history, the connection is harder but not impossible. Psoriatic arthritis is not on the PACT Act presumptive list, so the claim has to be built through medical records and a nexus opinion. Environmental exposures like burn pits, industrial chemicals, and dust have been tied to autoimmune conditions in medical literature, and that research can support the connection when the record is structured correctly.
What Happens at a C&P Exam for Psoriatic Arthritis?
The C&P exam for psoriatic arthritis can go in two directions, and which one it takes usually determines how the claim gets rated.
If the examiner treats it as a skin condition, the exam focuses on body coverage, treatment type, and medication history. That feeds the psoriasis rating but does nothing for the joint component. If the examiner evaluates the arthritis separately, they document which joints are affected, range of motion, signs of active inflammation, dactylitis, enthesitis, and what you report about episodes and daily impact. That goes into the Relevant DBQ and supports a DC 5002 rating.
The problem is that many exams default to the skin evaluation, especially when psoriasis is the primary service-connected condition. If the joint component is not specifically claimed and evaluated, the arthritis gets rolled in and never rated on its own.
Where Claims Lose Ground During the Exam
- The exam only covers the skin. If psoriatic arthritis was claimed but the examiner only evaluates psoriasis, the joint findings may not make it into the report at all.
- Joint symptoms sound like general pain. Saying “my hands hurt” does not distinguish psoriatic arthritis from anything else. The swelling pattern, the finger or toe involvement, the stiffness after inactivity, and the flare frequency are what separate PsA from degenerative joint pain.
- Flare-ups are not quantified. The DC 5002 criteria are built around how often incapacitating episodes happen. If the examiner does not document frequency and duration, the rating has no basis to go higher.
Before your exam, make sure psoriatic arthritis is specifically listed as a claimed condition, not just psoriasis. If both are claimed, the examiner should evaluate both. Bring a written summary of your joint flares, including which joints swell, how often it happens, how long episodes last, and what you cannot do during them. The skin exam and the joint exam need to produce separate findings.
What Evidence Helps Support a Higher Psoriatic Arthritis VA Rating?
The VA needs to see the arthritis as a separate condition from the skin disease. That means the record has to clearly show joint involvement independent of the psoriasis symptoms.
Stronger files usually include:
- Rheumatology records documenting joint-specific findings like dactylitis, enthesitis, or DIP joint involvement
- Documented incapacitating episodes with dates, duration, and impact on functioning
- Lab work showing inflammatory markers tied to the arthritis, not just the skin
- Imaging that shows joint changes, even if early imaging was normal
- Provider notes that describe the arthritis cycle separately from skin flares
- Lay statements describing what joint flares look like day to day, especially grip loss, finger swelling, or inability to walk
If the file only references psoriasis and mentions joint pain in passing, the arthritis is unlikely to be rated separately.
The biggest documentation gap in psoriatic arthritis claims is not severity. It is separation. If the record does not clearly distinguish joint symptoms from skin symptoms, the VA has no basis to assign two ratings. Before filing, check whether your medical records address the arthritis on its own or only as a footnote to the psoriasis.
What Secondary Conditions Can Be Linked to Psoriatic Arthritis?
Psoriatic arthritis is systemic. The same autoimmune process that attacks the joints and the skin can affect other parts of the body over time. Some of those conditions are already documented in the record but were never claimed separately.
What shows up most often:
Depression
Chronic pain, visible skin changes, and unpredictable flares create a pattern that often leads to depression. When mental health changes track with PsA progression, that connection can be documented and claimed.
Learn more →Anxiety / GAD
Social isolation from visible psoriasis combined with joint limitations can drive anxiety over time. When documented and tied to the autoimmune condition, it may support a separate rating.
Learn more →Sleep Apnea
Systemic inflammation and medication effects from PsA treatment have a documented connection to sleep disruption. Separately ratable when the records show the link.
Learn more →GERD
Long-term NSAID use for joint pain management is a well-documented cause of gastrointestinal problems. When the medication history ties back to PsA treatment, a secondary claim may be supportable.
Learn more →Fibromyalgia
Widespread pain and fatigue from PsA can overlap with or contribute to fibromyalgia. When both are documented, they can be evaluated as part of the broader disability picture.
Learn more →Peripheral Neuropathy
PsA-related inflammation can affect nerves over time, causing numbness, tingling, and pain in the extremities. When tied to the autoimmune process, it may support a separate rating.
Page coming soon
Example:
A veteran has psoriasis rated at 60% and psoriatic arthritis was never claimed separately. The record also shows worsening depression, chronic NSAID use causing reflux, and numbness in both hands. None of those conditions were filed. When they are documented and connected, the combined rating can look very different from the single 60% that currently stands.
What to Check Before Filing a Psoriatic Arthritis VA Claim
Before filing, look at the file the way a rater will.
- Is psoriatic arthritis listed as a separate claimed condition, or is it buried inside the psoriasis rating?
- Does the record clearly separate skin symptoms from joint symptoms?
- Are incapacitating joint episodes documented with dates, duration, and functional impact?
- Does the file show which joints are affected, including dactylitis or enthesitis if present?
- Is the C&P exam evaluating the arthritis on its own, or only covering the skin?
- Are secondary conditions from the disease or its treatment identified and connected?
Most psoriatic arthritis claims that stay low are not missing severity. They are missing the claim itself. Once the arthritis is separated from the psoriasis and evaluated under its own criteria, the rating picture usually changes.
Why Your Psoriatic Arthritis VA Rating Might Be Lower Than Expected
Most psoriatic arthritis ratings come in lower than expected because the arthritis was never split from the psoriasis. The VA rated the skin condition, the medication, and the body coverage, but the joint damage, the flares, and the functional loss were absorbed into a rating code that does not evaluate any of those things.
When the arthritis is separated out and rated under DC 5002, the criteria shift to incapacitating episodes, systemic health effects, and overall functional impairment. That is a completely different evaluation from skin coverage percentages.
We look at the file the same way a rater would and identify whether the conditions should be separated and what the documentation needs to show for each.
FAQs About Psoriatic Arthritis VA Ratings
Can I get separate VA ratings for psoriasis and psoriatic arthritis?
Yes. Psoriasis is rated under DC 7816 based on skin coverage and treatment. Psoriatic arthritis is rated under DC 5002 based on joint involvement, episodes, and health impact. Both can be rated separately as long as the symptoms do not overlap. The skin part counts for psoriasis, the joint part counts for psoriatic arthritis.
Is psoriatic arthritis rated the same as rheumatoid arthritis?
They use the same diagnostic code, DC 5002, with the same active process criteria. The difference is that psoriatic arthritis usually coexists with psoriasis, which creates the opportunity for a separate skin rating that does not exist with RA.
Can psoriatic arthritis be secondary to psoriasis?
Yes. This is the most common service connection path. About 30% of people with psoriasis develop psoriatic arthritis, and the medical literature supports the connection directly. If psoriasis is already service-connected, a provider opinion linking the arthritis to it is usually the clearest route.
What if my psoriasis and psoriatic arthritis are rated together under one code?
That is worth reviewing. If both conditions are rated under one diagnostic code, the joint component may not be getting its own evaluation. Separating them can change the combined rating significantly, especially when the arthritis is producing incapacitating episodes or functional limitations that the skin code does not account for.
Does medication that treats both conditions affect the rating?
It can. If you are on a biologic like Humira or methotrexate, that medication may support a higher psoriasis rating because it qualifies as systemic therapy. At the same time, if the arthritis still flares despite treatment, those episodes can support a DC 5002 rating. The medication helps both ratings, but only if both conditions are claimed and documented separately.
Can psoriatic arthritis be a presumptive condition?
Psoriatic arthritis is classified as a chronic disease, so if symptoms appeared at a compensable level within one year of discharge, the presumption of service connection can apply. It is not currently on the PACT Act presumptive list for burn pit exposure, but claims can still be filed with supporting medical evidence and a nexus opinion.